Clinical Social Workers in New London, WI Accepting Medicare

4 Clinical Social Workers found. Showing 1 - 4

Kathleen Grace Klingseisen, M.S.W., LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: E7475 Rawhide Rd, New London, WI 54961 Phone: 877-300-9101    Fax: 920-982-5040

Mrs. Anne Marie Collins-reed Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 315 River Road, New London, WI 54981 Phone: 715-281-9348

Lauren Mae Flunker, APSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: E7475 Rawhide Rd, New London, WI 54961 Phone: 920-531-2652    Fax: 920-982-5040

Miss Angelika Franziska Haas, M.S. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: E7475 Rawhide Rd, New London, WI 54961 Phone: 920-531-2660

News Archive

University of Calgary, City of Calgary partner to better protect ecosystem, improve public health

For the first time, university researchers are working side-by-side with municipal operators to advance wastewater treatment technologies and knowledge that will lead to cleaner water, a better protected ecosystem and improved public health.

Two UK studies reveal apparent increase in healthy ageing, less severe disability

Two studies conducted 20 years apart in England reveal an apparent increase in healthy ageing, or years lived healthily, reflecting less cognitive impairment; and an increase in the proportion of life lived healthily, through a larger proportion of years lived with disability but less rather than more severe disability.

UCSB neuroscientist provides new understanding of how the brain uses perception to guide action

A UC Santa Barbara researcher studying how the brain uses perception of the environment to guide action has a new understanding of the neural circuits responsible for transforming sensation into movement.

Novartis presents Phase II results of the QVA149 bronchodilator for the treatment of COPD

Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565) announce that Novartis have presented the results of their two Phase II studies evaluating the efficacy, safety and tolerability of QVA149 at the annual congress of the European Respiratory Society (ERS) in Vienna.

Early-onset familial Alzheimer disease provides clues to treatment of common Alzheimer's

The rarest kind of Alzheimer Disease (AD) - the form that transmits from parent to child with a cruel 50 percent likelihood - has been valued for its potential to shed light for the millions of people affected by the common form of AD.

Read more Medical News

› Verified 7 days ago